Mitochondrial Cyclophilin D in Vascular Oxidative Stress and Hypertension

作者：Itani Hana A; Dikalova Anna E; McMaster William G; Nazarewicz Rafal R; Bikineyeva Alfiya T; Harrison David G; Dikalov Sergey I^*

来源：Hypertension, 2016, 67(6): 1218-1227.

DOI：10.1161/HYPERTENSIONAHA.115.07085

• angiotensin II
• cyclophilin D
• endothelial oxidative stress
• hypertension
• inflammatory cytokines
• mitochondria
• vasorelaxation

Vascular superoxide (O-2(center dot-)) and inflammation contribute to hypertension. The mitochondria are an important source of O-2(center dot-); however, the regulation of mitochondrial O-2(center dot-) and the antihypertensive potential of targeting the mitochondria remain poorly defined. Angiotensin II and inflammatory cytokines, such as interleukin 17A and tumor necrosis factor-alpha (TNF alpha) significantly contribute to hypertension. We hypothesized that angiotensin II and cytokines cooperatively induce cyclophilin D (CypD)-dependent mitochondrial O-2(center dot-) production in hypertension. We tested whether CypD inhibition attenuates endothelial oxidative stress and reduces hypertension. CypD depletion in CypD(-/-) mice prevents overproduction of mitochondrial O-2(center dot-) in angiotensin II-infused mice, attenuates hypertension by 20 mm Hg, and improves vascular relaxation compared with wild-type C57Bl/6J mice. Treatment of hypertensive mice with the specific CypD inhibitor Sanglifehrin A reduces blood pressure by 28 mm Hg, inhibits production of mitochondrial O-2(center dot-) by 40%, and improves vascular relaxation. Angiotensin II-induced hypertension was associated with CypD redox activation by S-glutathionylation, and expression of the mitochondria-targeted H2O2 scavenger, catalase, abolished CypD S-glutathionylation, prevented stimulation mitochondrial O-2(center dot-), and attenuated hypertension. The functional role of cytokine-angiotensin II interplay was confirmed by co-operative stimulation of mitochondrial O-2(center dot-) by 3-fold in cultured endothelial cells and impairment of aortic relaxation incubated with combination of angiotensin II, interleukin 17A, and tumor necrosis factor-alpha which was prevented by CypD depletion or expression of mitochondria-targeted SOD2 and catalase. These data support a novel role of CypD in hypertension and demonstrate that targeting CypD decreases mitochondrial O-2(center dot-), improves vascular relaxation, and reduces hypertension.

• 出版日期2016-6